FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA has approved a supplemental application for Escitalopram Oxalate from Amneal Pharmaceuticals, indicating an approval of a new generic entry (ANDA 202227…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Escitalopram Oxalate (escitalopram oxalate)

Snippet

SUPPL AP for ESCITALOPRAM OXALATE (ESCITALOPRAM)